Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Basal Cell 3Pancreatic Neoplasms 2Urologic Neoplasms 1Urinary Bladder Neoplasms 1Telangiectasis 1Skin Neoplasms 1Rosacea 1Prostatic Neoplasms 1Precancerous Conditions 1Port-Wine Stain 1Pancreatic Intraductal Neoplasms 1Non-melanoma Skin Cancer 1Nevus, Pigmented 1Nasopharyngeal Neoplasms 1Mixed Tumor, Malignant 1Melanoma 1Lung Neoplasms 1Keratosis, Seborrheic 1Keratosis 1Hemangioma 1Glioma 1Carcinoma, Transitional Cell 1Carcinoma 1Barrett Esophagus 1

Interventions

Propranolol 8Timolol 5Prednisolone 4Prednisone 3Adrenergic beta-Antagonists 3Solutions 2Saline Solution 2Methylprednisolone 2Adrenal Cortex Hormones 2prednisolone phosphate 1Vincristine 1Tomography, Optical Coherence 1Steroids 1Sodium Chloride 1Sirolimus 1Population Groups 1Ointments 1Nadolol 1Mupirocin 1Leuprolide 1Lasers, Semiconductor 1Lasers, Dye 1Imiquimod 1Gels 1Everolimus 1Bleomycin 1Atenolol 1Acebutolol 168Ga-1,4,7-triazacyclononane-N,N',N''-triacetic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Hemangioma × Tomography, Optical Coherence × Clear all
NCT04336163 2024-01-30

Skin Imaging to Inform Laser Treatments

University of California, Irvine

Phase NA Terminated
55 enrolled 6 charts

Hemangioma, Rosacea, Telangiectasis, Port-Wine Stain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡